Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Express Scripts
Novartis
Dow
Baxter
Citi
Queensland Health
Federal Trade Commission
Cipla
Colorcon

Generated: January 19, 2018

DrugPatentWatch Database Preview

Zolmitriptan - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for zolmitriptan and what is the scope of zolmitriptan freedom to operate?

Zolmitriptan
is the generic ingredient in three branded drugs marketed by Astrazeneca, Alembic Pharms Ltd, Apotex Inc, Glenmark Generics, Jubilant Generics, Macleods Pharms Ltd, Zydus Pharms Usa Inc, Ajanta Pharma Ltd, Appco Pharma Llc, Aurobindo Pharma Ltd, Invagen Pharms, Mylan Pharms Inc, Pld Acquisitions Llc, Sun Pharma Global, Teva Pharms Usa, and IPR, and is included in twenty-two NDAs. There are two patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for zolmitriptan. Twenty suppliers are listed for this compound.

US Patents and Regulatory Information for zolmitriptan

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ajanta Pharma Ltd ZOLMITRIPTAN zolmitriptan TABLET;ORAL 204041-002 May 20, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Jubilant Generics ZOLMITRIPTAN zolmitriptan TABLET;ORAL 202279-001 Nov 20, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Inc ZOLMITRIPTAN zolmitriptan TABLET;ORAL 202078-002 May 14, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pld Acquisitions Llc ZOLMITRIPTAN zolmitriptan TABLET;ORAL 207867-002 Feb 27, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Jubilant Generics ZOLMITRIPTAN zolmitriptan TABLET, ORALLY DISINTEGRATING;ORAL 202956-001 Sep 17, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Astrazeneca ZOMIG zolmitriptan SPRAY;NASAL 021450-004 Sep 30, 2003 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Ipr ZOMIG zolmitriptan TABLET;ORAL 020768-001 Nov 25, 1997 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Astrazeneca ZOMIG zolmitriptan SPRAY;NASAL 021450-003 Sep 16, 2013 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Astrazeneca ZOMIG zolmitriptan SPRAY;NASAL 021450-004 Sep 30, 2003 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glenmark Generics ZOLMITRIPTAN zolmitriptan TABLET;ORAL 201779-002 May 14, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for zolmitriptan

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca ZOMIG-ZMT zolmitriptan TABLET, ORALLY DISINTEGRATING;ORAL 021231-002 Sep 17, 2001 ➤ Subscribe ➤ Subscribe
Astrazeneca ZOMIG zolmitriptan SPRAY;NASAL 021450-004 Sep 30, 2003 ➤ Subscribe ➤ Subscribe
Ipr ZOMIG zolmitriptan TABLET;ORAL 020768-002 Nov 25, 1997 ➤ Subscribe ➤ Subscribe
Ipr ZOMIG zolmitriptan TABLET;ORAL 020768-001 Nov 25, 1997 ➤ Subscribe ➤ Subscribe
Astrazeneca ZOMIG-ZMT zolmitriptan TABLET, ORALLY DISINTEGRATING;ORAL 021231-001 Feb 13, 2001 ➤ Subscribe ➤ Subscribe
Ipr ZOMIG zolmitriptan TABLET;ORAL 020768-001 Nov 25, 1997 ➤ Subscribe ➤ Subscribe
Ipr ZOMIG zolmitriptan TABLET;ORAL 020768-002 Nov 25, 1997 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Citi
McKesson
Baxter
Argus Health
QuintilesIMS
Boehringer Ingelheim
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot